Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization

Journal of Hepatology

Volumn 55, Issue 5, 2011, Pages 1034-1040

  Braren, Rickmer ^a   Altomonte, Jennifer ^a   Settles, Marcus ^a   Neff, Frauke ^b   Esposito, Irene ^a,b   Ebert, Oliver ^a   Schwaiger, Markus ^a   Rummeny, Ernst ^a   Steingoetter, Andreas ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

18F FDG PET; DCE MRI; DWI; Hepatocellular carcinoma; Multimodality multiparametric imaging; Transcatheter arterial embolization

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SIZE; CANCER TISSUE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EXTRACELLULAR SPACE; HISTOPATHOLOGY; INSTRUMENT VALIDATION; LIVER CELL CARCINOMA; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; TREATMENT OUTCOME; TUMOR NECROSIS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; EMBOLIZATION, THERAPEUTIC; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FLUORODEOXYGLUCOSE F18; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MULTIVARIATE ANALYSIS; NECROSIS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RATS; RATS, INBRED BUF; TUMOR BURDEN;

EID: 80054739534     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.01.049     Document Type: Article

References (33)

1. J.M. Llovet, A. Burroughs, and J. Bruix Hepatocellular carcinoma Lancet 362 2003 1907 1917 (Pubitemid 37518510)
2. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
3. J.M. Llovet, A.M. Di Bisceglie, J. Bruix, B.S. Kramer, R. Lencioni, and A.X. Zhu Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
4. R. Pang, and R.T. Poon Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma Cancer Lett 242 2006 151 167 (Pubitemid 44485315)
5. S. Tanaka, and S. Arii Molecularly targeted therapy for hepatocellular carcinoma Cancer Sci 100 2009 1 8
6. D. Ribatti, A. Vacca, B. Nico, D. Sansonno, and F. Dammacco Angiogenesis and anti-angiogenesis in hepatocellular carcinoma Cancer Treat Rev 32 2006 437 444 (Pubitemid 44309250)
7. L. Marelli, R. Stigliano, C. Triantos, M. Senzolo, E. Cholongitas, and N. Davies Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25 (Pubitemid 44900485)
8. C. Suzuki, H. Jacobsson, T. Hatschek, M.R. Torkzad, K. Boden, and Y. Eriksson-Alm Radiologic measurements of tumor response to treatment: practical approaches and limitations Radiographics 28 2008 329 344
9. R.L. Wahl, H. Jacene, Y. Kasamon, Lodge.M.A. From, and R.E.C.I. ST To PERCIST: evolving considerations for PET response criteria in solid tumors J Nucl Med 50 2009 122S 150S
10. M. Rudin, P.M. McSheehy, P.R. Allegrini, M. Rausch, D. Baumann, and M. Becquet PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo NMR Biomed 18 2005 308 321 (Pubitemid 41158696)
11. M.R. Young, L.V. Ileva, M. Bernardo, L.A. Riffle, Y.L. Jones, and Y.S. Kim Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography Neoplasia 11 2009 237 246 [231p. following 246]
12. A. Jackson Imaging microvascular structure with contrast enhanced MRI Br J Radiol 76 2003 S159 S173
13. M.O. Leach, K.M. Brindle, J.L. Evelhoch, J.R. Griffiths, M.R. Horsman, and A. Jackson The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations Br J Cancer 92 2005 1599 1610 (Pubitemid 40756468)
14. P.C. Liang, H.J. Ch'ang, C. Hsu, S.S. Tseng, T.T. Shih, and T. Wu Liu Dynamic MRI signals in the second week of radiotherapy relate to treatment outcomes of hepatocellular carcinoma: a preliminary result Liver Int 27 2007 516 528 (Pubitemid 46534574)
15. B. Taouli, and D.M. Koh Diffusion-weighted MR imaging of the liver Radiology 254 2010 47 66
16. D.M. Koh, and D.J. Collins Diffusion-weighted MRI in the body: applications and challenges in oncology AJR Am J Roentgenol 188 2007 1622 1635 (Pubitemid 46866868)
17. A.R. Padhani, G. Liu, D.M. Koh, T.L. Chenevert, H.C. Thoeny, and T. Takahara Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2009 102 125
18. A. Steingoetter, J. Svensson, Y. Kosanke, R.M. Botnar, M. Schwaiger, and E. Rummeny Reference region-based pharmacokinetic modeling in quantitative dynamic contract-enhanced MRI allows robust treatment monitoring in a rat liver tumor model despite cardiovascular changes Magn Reson Med 65 2011 229 238
19. T.J. Vogl, S. Zangos, J.O. Balzer, M. Nabil, P. Rao, and K. Eichler Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results Rofo 179 2007 1113 1126 (Pubitemid 350155118)
20. K. Shinozaki, O. Ebert, C. Kournioti, Y.S. Tai, and S.L. Woo Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus Mol Ther 9 2004 368 376 (Pubitemid 38404525)
21. S. Winkelmann, T. Schaeffter, T. Koehler, H. Eggers, and O. Doessel An optimal radial profile order based on the Golden Ratio for time-resolved MRI IEEE Trans Med Imaging 26 2007 68 76 (Pubitemid 46096351)
22. T.E. Yankeelov, G.O. Cron, C.L. Addison, J.C. Wallace, R.C. Wilkins, and B.A. Pappas Comparison of a reference region model with direct measurement of an AIF in the analysis of DCE-MRI data Magn Reson Med 57 2007 353 361 (Pubitemid 46214538)
23. Team RDC. R: A language and environment for statistical computing; 2010. < http://www.bibsonomy.org/bibtex/2b73bfa376907e90089cf7434f67bfd53/yevb0? layout=simplehtml >.
24. J. Altomonte, R. Braren, S. Schulz, S. Marozin, E.J. Rummeny, and R.M. Schmid Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats Hepatology 48 2008 1864 1873
25. M.A. Khan, C.S. Combs, E.M. Brunt, V.J. Lowe, M.K. Wolverson, and H. Solomon Positron emission tomography scanning in the evaluation of hepatocellular carcinoma J Hepatol 32 2000 792 797 (Pubitemid 30262739)
26. J. Trojan, O. Schroeder, J. Raedle, R.P. Baum, G. Herrmann, and V. Jacobi Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma Am J Gastroenterol 94 1999 3314 3319
27. S. Metz, C. Ganter, S. Lorenzen, S. van Marwick, K. Herrmann, and F. Lordick Phenotyping of tumor biology in patients by multimodality multiparametric imaging: relationship of microcirculation, alphavbeta3 expression, and glucose metabolism J Nucl Med 51 2010 1691 1698
28. C.J. Galban, M.S. Bhojani, K.C. Lee, C.R. Meyer, M.E. Van Dort, and K.K. Kuszpit Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-d- glucose-positron emission tomography imaging biomarkers Clin Cancer Res 16 2010 1542 1552
29. K. Herrmann, R.A. Bundschuh, R. Rosenberg, S. Schmidt, C. Praus, and M. Souvatzoglou Comparison of different SUV-based methods for response prediction to neoadjuvant radiochemotherapy in locally advanced rectal cancer by FDG-PET and MRI Mol Imaging Biol 2010
30. M. Aref, A.R. Chaudhari, K.L. Bailey, S. Aref, and E.C. Wiener Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates Magn Reson Imaging 26 2008 1279 1293
31. F. Kiessling, M. Le-Huu, T. Kunert, M. Thorn, S. Vosseler, and K. Schmidt Improved correlation of histological data with DCE MRI parameter maps by 3D reconstruction, reslicing and parameterization of the histological images Eur Radiol 15 2005 1079 1086 (Pubitemid 40778728)
32. H.C. Thoeny, F. De Keyzer, F. Chen, Y. Ni, W. Landuyt, and E.K. Verbeken Diffusion-weighted MR imaging in monitoring the effect of a vascular targeting agent on rhabdomyosarcoma in rats Radiology 234 2005 756 764 (Pubitemid 40250819)
33. H.C. Thoeny, F. De Keyzer, F. Chen, V. Vandecaveye, E.K. Verbeken, and B. Ahmed Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration Neoplasia 7 2005 779 787